About Pudee

Reliability, Responsibility and Rapidity

Founded in 2007, focus on the synthesis of small molecule compounds and the extraction of some natural compounds. We develop, produce and sell high-quality advanced intermediates and some APIs with competitive prices.
Get Appointment

Contact Info

  • Building 2, Handa Science and Technology Park
    No. 8 Pioneer Road
    High-tech Zone. Suzhou.
  • 86 512 6803 2792
    86 512 6803 2791
  • willdyhan@pudeepharm.com
    sales@pudeepharm.com

Product Details

Fostamatinib intermediate 3

Fostamatinib intermediate 3 | 1002726-59-1

Chemical Name: 2,2-Dimethyl-6-nitro-2H-pyrido[3,2-b]-1,4-oxazin-3(4H)-one

CAS Number: 1002726-59-1
Formula: C9H9N3O4
Molecular weight: 223.19

Product Description

"

Fostamatinib is an experimental drug candidate for the treatment of a variety of diseases, originally developed by Rigel Pharmaceuticals. The drug is administered orally as a disodium salt, and is a prodrug of the active compound tamatinib which is an inhibitor of the enzyme spleen tyrosine kinase (Syk) hence it is an syk inhibitor.

Syk is a protein tyrosine kinase associated with various inflammatory cells, including macrophages, which are presumed to be the cells responsible for ITP platelet clearance.

Syk plays an important role in FcγR-mediated signal transduction and inflammatory propagation, it is considered a good target for the inhibition of various autoimmune conditions, including rheumatoid arthritis and lymphoma.

One of intermediates of Fostamatinib, the appearance is yellow powder solid, the purity is not less than 98% by HPLC.

"